These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26043182)

  • 1. Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay.
    Eckl-Dorna J; Campana R; Valenta R; Niederberger V
    Allergy; 2015 Oct; 70(10):1222-9. PubMed ID: 26043182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis.
    Wong KJ; Timbrell V; Xi Y; Upham JW; Collins AM; Davies JM
    Allergy; 2015 Apr; 70(4):420-8. PubMed ID: 25556717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG
    Eckl-Dorna J; Weber M; Stanek V; Linhart B; Ristl R; Waltl EE; Villazala-Merino S; Hummel A; Focke-Tejkl M; Froeschel R; Neubauer A; Henning R; Perkmann T; Valenta R; Niederberger V
    EBioMedicine; 2019 Dec; 50():421-432. PubMed ID: 31786130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens.
    Aghayan-Ugurluoglu R; Ball T; Vrtala S; Schweiger C; Kraft D; Valenta R
    J Allergy Clin Immunol; 2000 Apr; 105(4):803-13. PubMed ID: 10756233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.
    Campana R; Moritz K; Marth K; Neubauer A; Huber H; Henning R; Blatt K; Hoermann G; Brodie TM; Kaider A; Valent P; Sallusto F; Wöhrl S; Valenta R
    J Allergy Clin Immunol; 2016 Feb; 137(2):601-609.e8. PubMed ID: 26518092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens.
    Dolecek C; Steinberger P; Susani M; Kraft D; Valenta R; Boltz-Nitulescu G
    Clin Exp Allergy; 1995 Sep; 25(9):879-89. PubMed ID: 8564727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
    Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
    Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.
    Eckl-Dorna J; Villazala-Merino S; Linhart B; Karaulov AV; Zhernov Y; Khaitov M; Niederberger-Leppin V; Valenta R
    Front Immunol; 2018; 9():3131. PubMed ID: 30705676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
    J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing.
    Heiss S; Mahler V; Steiner R; Spitzauer S; Schweiger C; Kraft D; Valenta R
    J Invest Dermatol; 1999 Nov; 113(5):830-7. PubMed ID: 10571741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of macrophages in the initiation of allergic rhinitis in mice sensitized intranasally once with cedar pollen: regulation of class switching of immunoglobulin in B cells by controlling interleukin-4 production in T cells of submandibular lymph nodes.
    Hirano M; Ogita-Nakanishi H; Miyachi W; Hannya N; Yamamoto-Kimoto Y; Sakurai K; Miyoshi-Higashino M; Tashiro-Yamaji J; Kato R; Ijiri Y; Tanaka K; Kanazawa A; Terada T; Kawata R; Takenaka H; Kubota T; Yoshida R
    Microbiol Immunol; 2012 Jun; 56(6):392-405. PubMed ID: 22404751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses.
    Jenmalm MC; Björkstén B; Macaubas C; Holt BJ; Smallacombe TB; Holt PG
    Pediatr Allergy Immunol; 1999 Aug; 10(3):168-77. PubMed ID: 10565557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms.
    Niederberger V; Niggemann B; Kraft D; Spitzauer S; Valenta R
    Eur J Immunol; 2002 Feb; 32(2):576-84. PubMed ID: 11828375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
    Asero R; Mistrello G; Amato S
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
    Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.